Monday, April 13, 2015
Study published confirming intraaortic balloon pumps as the clinically and economically cost-effective first line choice for high-risk PCI patients
Maquet Cardiovascular USA has announced the publication of a manuscript comparing the clinical and economic impact of percutaneous ventricular assist devices (pVAD) with intraaortic balloon pumps...Study published confirming intraaortic balloon pumps as the clinically and economically cost-effective first line choice for high-risk PCI patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.